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ABSTRACT
The early stages of homing, seeding, and engraftment of hematopoietic stem and progenitor cells are poorly
characterized. We have developed an optical technique that allows in vivo tracking of transplanted, fluorescent-
tagged cells in the host femurs. In this study we used fluorescence microscopy to monitor the topologic and
chronologic patterns of hematopoietic cell seeding in the femoral bone marrow (BM) of mice. PKH-labeled
cells homed to the femur within minutes after injection into a peripheral vein. Most cells drifted within the
marrow space and gradually seeded in clusters close to the endosteal surface of the epiphyseal cortex. Three
days after transplantation 85% to 94% (14%) of PKH-labeled cells in the femoral marrow were located within
100 m of the epiphyseal bone surface (P < .001 versus the more central cells), whereas labeled cells were
absent in the femoral diaphysis. Primary seeding of juxtaendosteal, epiphyseal marrow occurred independently
of recipient conditioning (myeloablated and nonconditioned hosts), donor-recipient antigen disparity, or the
phenotype of the injected cells (whole BM and lineage-negative cells) and was consistently observed in
secondary recipients of BM-homed cells. Seeding in regions close to the epiphyseal bone was also observed in
freshly excised femurs perfused ex vivo and in femurs assessed without prior placement of optical windows,
indicating that the site of primary seeding was not affected by surgical placement of optical windows. Four to
5 days after transplantation, cellular clusters appeared in the more central regions of the epiphyses and in the
diaphyses. Centrally located cells showed decreased PKH fluorescence, suggesting that they were progeny of
the seeding cells, and brightly fluorescent cells (quiescent first-generation seeding cells) were observed close
to the bone surface for as long as 24 days after transplantation. These data indicate that the periphery of the
femoral marrow hosts primary seeding and that quiescent cells continue to reside in the periphery for weeks
and do not divide. The site of proliferation of transplanted cells is the center of the marrow space.
© 2003 American Society for Blood and Marrow Transplantation
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INTRODUCTION
Engraftment of hematopoietic cells has been ex-
tensively studied for 3 decades, yet the initial events
that follow the infusion of donor stem cells into the
host remain shrouded in mystery deep within the host
marrow space. In the absence of adequate techniques
to assess the early stages of hematopoietic cell engraft-
ment in real time, most studies rely on assays per-
formed days to weeks after transplantation and involve
the use of ex vivo and in vitro techniques that can
disturb the normal topology of the marrow space. The
early stages of bone marrow cell (BMC) engraftment
in the host are crucial determinants of the long-term
success of the procedure. As such, reliable studies of
the early-engraftment parameters would facilitate
short-term assays as surrogates for assessment of the
transplantation success and streamline evaluation of
laboratory models of stem cell transplantation. To
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study the critical early processes of homing and seed-
ing, we have developed novel techniques for real-time,
in vivo tracking of labeled cells in recipient bone
marrow (BM) in physiological conditions [1]. The
objective of this study was to monitor the topologic
organization and the chronologic patterns of seeding
of the transplanted cells in the recipient femur in vivo.
Hematopoietic cells in various developmental
stages occupy distinct sites within the BM. Primitive
cells align along the bone surface, and more mature
progenitors occupy the central regions of the marrow
[2-4]. Colony-forming cells are abundant in proximity
to the bone cortex in normal mice and are sparse in
more remote regions of the marrow space [5-7]. In the
transplantation setting, human hemopoietic stem cells
display preferential seeding in the epiphyseal plates of
femurs of severe combined immune deﬁciency mice
[8]. It was postulated that transplanted cells are en-
trapped by the dense matrix of the BM; therefore,
homing and seeding may be stochastic events [9,10].
In contrast, it was shown that these early engraftment
events are selective and responsive to a variety of local
chemotactic factors [11]. Transplanted cells seem to
seed preferentially in the periphery of the marrow
space, reﬂecting a high afﬁnity of hemopoietic pro-
genitors for endosteal surfaces [12,13]. In vitro, he-
mopoietic cells show more robust viability when
cocultured in stromal cultures that contain osteoblasts
[14], and transplantation outcomes are superior in
mice when osteoblasts are added to donor BMC in-
oculum [15-17]. We have recently shown in situ
crawling of transplanted BMC under the BM stroma
toward the inner bone surface, a process that may
facilitate the interaction of BMC with osteoblasts and
the extracellular matrix [18].
We have performed a systematic characterization
of the early events in hematopoietic cell engraftment
to determine whether study of this period will provide
reliable clues to the long-term outcome of hemato-
poietic reconstitution. Recently, we reported forma-
tion of clusters of transplanted cells in the marrow
space and an abundance of putative sites for adhesion
that are not inﬂuenced by antigen disparity between
the donor cells and the host stromal microenviron-
ment [18,19]. In this study, we present data on the
topologic and chronologic patterns of hematopoietic
cell seeding in the mouse femur.
MATERIALS AND METHODS
Animal Preparation and Conditioning
B10 (C57BL/10SNJ, H2b) and B10.BR (C57BL/
BR, H2k) mice purchased from Jackson Laboratories
(Bar Harbor, ME). Animas were housed in a patho-
gen-free facility and were treated in accordance with
the institutional and National Institutes of Health
guidelines. Mice aged 8 to 12 weeks were anesthetized
with Avertin (2,2,2-tribromoethanol, 12-17 g/g in-
traperitoneally), and respiration was monitored with a
PowerLab piezoelectric transducer (ADInstruments,
Grand Junction, CO). Additional doses of anesthetic
(Avertin 6 g/g intraperitoneally) were administered
when respiration rates exceeded 0.5 Hz to prevent
awakening. Motion, access to food and water, and
general behavior were monitored frequently during
the postoperative period and at daily intervals there-
after. Myeloablative conditioning was performed with
busulfan (90% lethal dose, 145 g/g) or total body
irradiation (TBI; 950 cGy). Busulfan was dissolved in
dimethyl sulfoxide at a concentration of 24 mg/mL,
diluted 5-fold in water at 41°C (Sigma, St. Louis,
MO), and administered intraperitoneally 36 hours be-
fore cell transplantation to avoid toxic effect of its
metabolites on the donor cells. Irradiation was per-
formed 6 hours before cell transplantation at a rate of
105 cGy/min by using a Cesium 137 source (J.L.
Sheppard, San Fernando, CA). Donor cells suspended
in 0.2 mL of phosphate-buffered saline (PBS) were
injected into the lateral tail vein.
Surgical Procedure
To visualize the recipient BM microenvironment,
an optical window was placed over the distal femoral
epiphysis under aseptic conditions, as previously de-
scribed [1]. Brieﬂy, the femur was exposed, and a
2.5  4-mm area of the bone cortex was thinned with
an electrical drill. On appearance of ﬁssures in the
eroded area, the bone plates were removed with ﬁne-
tipped forceps. Neocryl dental cement (NeoResins,
Wilmington, MA) was applied to the edge of the
exposed area to secure a 3  5-mm glass window
(coverslip #0) over the diaphysis. The quadriceps mus-
cle was sutured to one of the skin ﬂaps, the skin was
closed (4-O silk sutures), and the limb was casted with
gauze and Neocryl in a semiﬂexed position.
Isolation and Staining of the BMCs
BMCs were harvested by crushing from femora
and tibia of donor mice in Hanks balanced salt solu-
tion (HBSS; Gibco, Grand Island, NY), as previously
described [1,18]. Brieﬂy, BMC were suspended, ﬁl-
tered (30 m), collected by centrifugation (400g, 10
minutes, 4°C), and resuspended in HBSS containing
2% fetal calf serum. Red blood cells were lysed by
incubation with ammonium chloride for 4 minutes at
room temperature. Nucleated cells were counted after
being washed twice with excess medium (whole
BMC). Low-density cells were collected by centrifu-
gation (20 minutes, 4°C, 800g) from a density gradient
column at 1.087 g/mL (CedarLane, Ontario, Canada).
Lineage-negative cells were isolated by incubation
with saturating amounts of rat anti-mouse monoclonal
Femoral Topology of Hematopoietic Cell Seeding
497BB&MT
antibodies (mAb) speciﬁc for CD5 (clone 53-7.3),
GR-1 (clone RB6-8C5), CD45R (clone RA3-6B2),
Ly-76 (clone TER119), TCR- (clone H57-597),
and TCR- (clone GL3); Pharmingen, San Diego,
CA) for 30 minutes at 4°C. Cells coated with mAb
were washed twice with PBS containing 1% bovine
serum albumin and were incubated with sheep anti-rat
immunoglobulin G conjugated to M-450 magnetic
beads at a ratio of 4 beads per cell (Dynal, Lake
Success, NY). Rosetted cells were precipitated in a
magnetic ﬁeld, and the supernatant (lineage-negative
cells) was collected. The average yield of this proce-
dure was 4% to 5%, of which 95% were viable as
assayed with the trypan blue exclusion test.
Cells were suspended in diluent C at a concentra-
tion of 2  107/mL, and freshly prepared PKH26 or
PKH67 dyes (Sigma): were added to a ﬁnal concen-
tration of 2 M [1,18]. The samples were incubated
with PKH membrane linkers at room temperature for
5 minutes with gentle mixing. Staining was terminated
by the addition of 4 volumes of HBSS containing 10%
fetal calf serum, and cells were collected by centrifu-
gation (10 minutes, 4°C, 400g) and washed twice with
HBSS. The labeling efﬁciency of this procedure was
85%, with a viability of 95%, as assayed with the
trypan blue exclusion test.
Characterization of Donor Chimerism
Blood samples from the tail vein were collected
into heparinized serum vials in 200 L of HBSS, red
blood cells, were lysed, and the nucleated cells were
incubated with ﬂuorescein isothiocyanate–labeled an-
tirecipient (clone AF6-88.5) and phycoerythrin-la-
beled anti-donor mAb (clone 36-7-5); (Pharmingen).
Low-density BMC were collected by centrifugation
(20 minutes, 4°C, 800g) from lymphocyte separation
media (CedarLane), washed twice with HBSS, and
ﬁxed with 0.5% paraformaldehyde. The percentage of
B10.BR donor (H2k) and B10 recipient (H2b) periph-
eral blood lymphocytes was characterized by ﬂow cy-
tometry (Coulter Elite, Miami, FL) in the lymphocyte
gate.
In Situ Infusion of Cells into Windowed Femurs
Femurs were harvested 4 days after placement of
the bone window from mice killed by CO2 asphyxia-
tion under anesthesia. BMC suspended in PBS (106/
mL) were injected into the femoral lumen through
26-gauge blunt needles by using a microperfusion
pump (P720; Instech, Plymouth Meeting, PA) at 0.1
mL/min. Nonadherent cells were removed by perfu-
sion of the femoral lumen with PBS for 10 minutes at
0.1 mL/min [18].
In Vivo and In Situ Cellular Tracking with
Fluorescence Microscopy
Animals were anesthetized, the cast and sutures
were removed, skin and quadriceps muscle were re-
ﬂected, and connective tissue was removed from the
window with a scalpel blade under aseptic conditions
[1]. Animals were mounted on the microscope stage,
and the leg was immobilized without obliteration of
blood supply. Each recipient was sequentially moni-
tored by in vivo microscopy 2 to 4 times, a procedure
associated with a mean death rate of 12%. The most
prevalent cause of death was failure to recover from
anesthesia, which was given in high doses to minimize
motion artifacts during image acquisition. Direct ob-
servation of the PKH26- and PKH67-labeled cells in
recipient BM was performed with Eclipse 800 (Nikon,
Melville, NY) and Axioplan (Carl Zeiss, Thornwood,
NY) upright ﬂuorescence microscopes and appropri-
ate sets of ﬁlters (Chroma Technology, Brattleboro,
VT). The bone windows were ﬁrst inspected at 4X
magniﬁcation, and a map containing discrete coordi-
nates in reference to the window frame was drawn by
using a computerized microscope stage controlled by
QED software (QEDImaging, Pittsburgh, PA). The
BM was then optically inspected at magniﬁcations of
10 to 100X for a better spatial resolution.
Image Acquisition and Analysis
Images were collected with a change-coupled de-
vice camera (Hamamatsu Photonics KK, Hamamatsu,
Japan), processed with the QED software, and
pseudocolored to simulate the real hues (Adobe Pho-
toshop software). The ﬁgures were reconstituted in 2
ways: (1) superposition of ﬂuorescence images over
brightﬁeld color images of the same area of the BM
and (2) red-green-blue reconstruction using superpo-
sition of 3 layers of ﬂuorescence acquired at the same
magniﬁcation and position of the stage—red, rhoda-
mine ﬁlters for the detection of PKH26; green, ﬂuo-
rescein ﬁlters for PKH67; and blue, a standard set of
46-diamidino-2-phenylindole-2 HCl ﬁlters to detect
UV-excited bone autoﬂuorescence.
Experimental Procedure
The standard experimental procedure included
surgery for placement of the bone window on day 4;
mice were allowed to recover. Myeloablative condi-
tioning was performed by the administration of 1 dose
of busulfan 145 g/g (36 hours before transplantation)
or 950 rad of TBI given in 1 dose 6 hours before cell
transplantation. On day 0, donor cells labeled with
PKH membrane liners were injected into the tail vein:
2  106 syngeneic or 107 allogeneic whole BMC and
2  104 syngeneic or 105 allogeneic lineage-negative
BMC.
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Statistical Analysis
Data are presented as means 	 SD for each ex-
perimental protocol. Numbers of cells determined in
various animals at the same time point were evaluated
for reproducibility by analysis of variance. Differences
between the experimental protocols were evaluated
with a post hoc Scheffe´ t test.
RESULTS
Topologic Organization of Primary Cellular
Seeding in Recipient BM In Vivo
The spatial distribution of transplanted cells was
monitored in vivo through optical windows placed
Figure 1. Distribution of hematopoietic cells in recipient bone
marrow 3 days after transplantation. Optical windows were placed
over distal femoral epiphysis (day 4), and B10 recipients were
conditioned with busulfan 145 g/g (day 1.5). A total of 107
PKH26-labeled BMC from B10.BR donors were injected intrave-
nously on day 0. Images were acquired with a Nikon Eclipse 800
microscope at a magniﬁcation of 4x at the location depicted in the
insert. The ﬁgure was reconstructed from three red-green-blue
layers: red, PKH26-labeled cells detected with a rhodamine set of
ﬁlters; green, background ﬂuorescence of BM stroma detected with
a ﬂuorescein set of ﬁlters; blue, UV-induced bone autoﬂuorescence
detected with a 46-diamidino-2-phanylindole-2 HCl (DAPI) set of
ﬁlters. The low-resolution image presents the peripheral seeding of
transplanted cells in proximity to the epiphyseal bone surface and at
the base of osseous trabeculae close to the optical window, which
replaced the excised bone cortex.
Figure 4. Seeding of infused cells in the peripheral regions of the
epiphyses is an intrinsic property of femoral BM stroma. Femurs
freshly excised from B10 mice were infused in situ with PKH67-
labeled BMC from B10.BR donors. Nonadherent cells were re-
moved by gentle perfusion of the femoral lumen with PBS. The
ﬂuorescence image was acquired with an Axioplan microscope (Carl
Zeiss) at a magniﬁcation of 10x at the location depicted in the insert.
The images are representative of 5 independent experiments and
show (A) that primary seeding was close to the bone surface in
femoral epiphysis and (B) that transplanted cells do not seed in
femoral diaphysis.
Š
Figure 2. High-resolution in vivo tracking of cells labeled with
PKH67. B10 recipients were operated on for placement of a bone
window (day4), conditioned with busulfan 145 g/g (day1.5), and
injected with 2  106 syngeneic BMC labeled with PKH67. Images
were acquired with aNikon Eclipse 800microscope, and the ﬁgure was
reconstructed by superposition of a ﬂuorescence layer (PKH67) over a
color image acquired in brightﬁeld. The ﬂuorescence layer was dis-
played in pseudocolor to simulate the real hues. A, Three days after
transplantation, a cluster of 6 to 7 cells was seen at the edge of the
epiphyseal endosteum at a location shown in the insert (magniﬁcation,
of 40x). B, Twenty-four days after transplantation, 2 brightly-ﬂuores-
cent cells were seen, indicating that they did not divide (magniﬁcation,
63x). The cells were located in proximity to bone surface (yellow
arrows) at the approximate location shown in the insert.
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over the femoral marrow. Several minutes after intra-
venous injection, some PKH-labeled cells appeared in
the marrow space. These cells were mobile and drifted
with the blood pulsation, suggesting nonadherence.
Gradually, some cells became immobilized, indicating
seeding in BM stroma, and other cells disappeared
from the ﬁeld of view. Most of the immobile PKH-
labeled cells were located in the periphery of the
femoral epiphyses near the bone cortex. Figure 1 pre-
sents a low-magniﬁcation reconstructed image of the
distal femoral epiphysis, showing peripheral seeding
of PKH26-labeled cells. The cells seeded at the base
of the bone trabeculae that protrude into the marrow
space and also close to the cortical sites where the
bone was replaced with the optical window. During
this initial period of assessment, immobile cells were
not seen either in the femoral diaphyses or the central
regions of the epiphyses. A more detailed analysis of
the patterns of seeding, performed at higher magniﬁ-
cations (Figure 2A), revealed that the transplanted
cells seeded in clusters [19].
Topologic organization of seeding was assessed in
a syngeneic BMT model (H2b3H2b). We focused on
measurements performed 24 and 72 hours after trans-
plantation, when 74% and 97% of the transplanted
cells are adherent, respectively (unpublished data).
Seeding was evaluated after transplantation of PKH-
labeled whole BMC and lineage-negative BMC into
nonconditioned mice and in mice conditioned with
either busulfan or TBI (Table 1). In all these experi-
mental conditions, peripheral seeding was statistically
signiﬁcant versus central seeding of the cells (P 

.001).
To determine whether the observed cells en-
grafted, the hosts were monitored for survival and
levels of donor hematopoietic chimerism. The mor-
tality rates of myeloablated H2b recipients (either ir-
radiation or busulfan) injected with cell-free medium
were 90% and 100%, respectively (n  10 in each
group). Injection of 2  106 H2b and 107 H2k whole
BMC rescued 100% and 83% of the H2b myeloab-
lated hosts, respectively. All nonconditioned recipi-
ents survived for periods exceeding 4 months. To
characterize the cells observed through the optical
window, both femurs were excised on day 3 after
transplantation, and the phenotype of BM-homed
cells was determined by ﬂow cytometry. Approxi-
mately 14% of the cells in both the windowed and
naive contralateral femurs were PKH positive (Figure
3B). The femoral PKH cells were enriched in prim-
itive lineage-negative SCA-1 cells (22%	 3% versus
8% 	 1% in donor inoculum; P 
 .001), in lineage-
positive SCA-1 cells (11% 	 1% versus 6.4% 	
0.8% in donor inoculum; P 
 .001), and in lineage-
positive SCA-1 cells (8%	 1% versus 2.4%	 0.3%
in donor inoculum; P 
 .001; Figure 3C). At 4 weeks
after transplantation, these mice were 78% 	 6%
donor (H2k) chimeras (Figure 3D), and 20% 	 3% of
the donor cells were CD3 positive (not shown).
To further assess whether the observed cells were
indeed engrafting cells that were responsible for du-
Figure 3. Transplantation of immunomagnetically puriﬁed lineage-
negative (lin) cells into myeloablated allogeneic recipients. A,
Immunomagnetically puriﬁed lin cells had a purity of 95% and
a viability of 95% as assayed by staining with a cocktail of ﬂuo-
rescein isothiocyanate–labeled antibodies against lineage markers
and propidium iodide (PI), respectively, B, A total of 105 lin H2k
cells were injected into busulfan-myeloablated H2b recipients (n 
6). On day 3, the recipients were killed, and a mean of 930 	 40
PKH-labeled cells were sorted by ﬂow cytometry from each femur.
The portion of PKH-labeled cells was approximately 14% of a 200
to 700 forward-scatter and 0 to 300 side-scatter gate. There were no
signiﬁcant differences in homing of PKH-labeled cells to windowed
and naive femurs. C, On day 3 after transplantation, the PKH-
positive cells contained 22% 	 3% lin SCA-1 cells (P 
 .001
versus 8% 	 1% in donor inoculum), 8% 	 1% lin SCA-1 cells
(P 
 .001 versus 2.4% 	 0.3% in donor inoculum), and 11% 	 1%
lin SCA-1 cells (P 
 .001 versus 6.4% 	 0.8% in donor inocu-
lum). D, Four weeks after transplantation, the peripheral blood of
H2b chimeras was 78% 	 6% of the H2k donor phenotype.
Table 1. Peripheral Seeding of PKH Labeled Cells*
Host n
Myeloablative
Conditioning Donor Cells
Peripheral
Seeding
(%)
H2b 9 None H2b wBMC 85  6
H2b 6 TBI H2b wBMC 94  3
H2b 15 Busulfan H2b wBMC 89  5
H2b 6 None H2b lin BMC 93  3
H2b 6 None H2k lin BMC 89  4
H2b 12 Busulfan H2k lin BMC 85  6
*Percentage of cells that seeded in within 100 m from the
endosteal bone surface within the ﬁrst 3 days after transplantation of
PKH-labeled whole BMC (wBMC) or lineage-negative (lin) BMC
into hosts without conditioning and after myeloablation with busul-
fan and total body irradiation (TBI).
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rable hematopoietic reconstitution of the myeloab-
lated hosts, day 3 BM-homed cells were transplanted
into secondary hosts. Busulfan-myeloablated H2b pri-
mary hosts were killed 3 days after transplantation of
PKH-labeled H2k cells, and the femurs were har-
vested. The cellular contents of femurs from 4 pri-
mary recipients (approximately 8000 H2k cells) were
injected intravenously into secondary hosts with pre-
placed optical windows (n  5). Although the num-
bers of PKH-labeled cells observed through the fem-
oral windows in the secondary recipients were
relatively small (in the order of 20-30 cells), these cells
maintained the topologic seeding preference in sec-
ondary hosts that was seen in the primary transplant.
Despite the low seeding efﬁciency, secondary hosts
were full hematopoietic chimeras (94% 	 4% donor
cells) at 12 weeks after transplantation. Because more
than 85% of PKH donor cells at day 3 in primary
recipients were found in the periphery of the marrow
space, donor engraftment in secondary hosts is likely
the result of transplantation of these peripherally
seeding cells.
Secondary Cellular Seeding in the Femoral Bone
Marrow
PKH-labeled donor cells appeared as clusters in
the more central regions of the epiphysal and diaph-
yseal marrow of both primary and secondary hosts on
day 4 to 5 after transplantation. This centripetal mi-
gration was accompained by dilution and increased
heterogeneity in PKH labeling of cells, which was
suggestive of the onset of cellular division [19], and by
a decrease in the number of cells per cluster. In con-
trast, some cells remained in the periphery of the
femoral marrow space for periods exceeding 3 to 4
weeks and retained bright PKH ﬂuorescence (Figure
2B). These brightly ﬂuorescent cells could represent
either mature, differentiated (nonproliferating) cell
subsets or quiescent stem cells. Observation of the
cells for weeks after transplantation of lineage-nega-
tive BMC indicates that some of these cells were
quiescent hemopoietic stem and progenitor cells.
Cellular Seeding In Situ
The stereotypic topology of primary seeding of
infused BMC at day 3 could be a result of migration of
infused cells to speciﬁc locations within the marrow
space, or, alternatively, it could result from preferen-
tial blood ﬂow to these areas that results in settling of
cells in the ﬁrst hospitable location that they encoun-
ter within the marrow space. To test these 2 possibil-
ities, we compared the topology of seeding after either
conventional intravenous transplantation or direct ap-
plication of stem cells to the marrow space. Freshly
excised, windowed femurs from myeloablated and
nonconditioned H2b mice were directly infused with
PKH-labeled H2k cells in situ. After infusion of the
PKH cells, the nonadherent cells were ﬂushed by
perfusion with cell-free medium at a rate previously
shown to remove only free-ﬂoating cells [18]. Figure 4
presents characteristic images of the in situ seeding
patterns of cells infused into the femurs, showing
nearly exclusive, selective seeding in the epiphyses
(Figure 4A) and a absence of donor cells in the femoral
diaphysis (Figure 4B).
Assessment of the Surgical Procedure
Our experimental approach is based on surgical
placement of a transparent window over the recipient
femoral marrow space. To assess whether surgical
manipulation affected the topologic pattern of BMC
lodging, we performed 2 control experiments. First,
PKH-labeled syngeneic BMC were injected into H2b
recipients without placement of bone windows (n 
3). The mice were killed, and their femurs were har-
vested 2 days after transplantation. The bone cortex of
the femur was removed ex vivo by a sharp longitudinal
incision, and the contents of the BM were inspected
by ﬂuorescence microscopy. As seen in windowed
femora, PKH-labeled donor cells were present exclu-
sively in the subendosteal regions of the epiphyses,
indicating that our ﬁndings were not an artifact of
surgical manipulation of the femur.
In a second control experiment, bone windows
were placed over the femoral diaphysis. After myelo-
ablation, H2b recipients were injected intravenously
with 2  106 PKH-labeled syngeneic whole BMC.
PKH-labeled cells were not seen through the diaph-
yseal window, suggesting that surgical manipulation of
the bone does not increase seeding in sites outside of
the epiphysis (n 4). These data indicate that surgical
manipulation did not change the topologic and chro-
nologic patterns of cellular seeding in the femoral
marrow space and that possible elaboration of homing
molecules in the callus that forms near the margins of
the optical window did not account for the observed
topology of seeding.
DISCUSSION
This study exploits a novel imaging technique to
monitor the topologic organization of donor hemato-
poietic stem cell seeding in the recipient marrow cav-
ity as a function of time after transplantation. This
technique avoids the unavoidable artifacts that are
associated with ex vivo manipulations that can distort
the delicate architecture of the bone marrow and re-
sult in spillage of cells from the vascular space into the
marrow cavity during sample preparation. In addition,
approximately 50% of initially homing cells do not
seed in the femoral marrow [20]; however, they would
be passively trapped during sample preparation within
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the ﬁrst 2 or 3 days after transplantation. The optical
window used in this study visualizes the actual mar-
row, excluding the intravascular space, thus discrimi-
nating cells that have actually migrated into the mar-
row cavity from PKH-labeled cells that are transiting
through blood vessels within the marrow.
Although syngeneic and allogeneic BMC circulate
in the host peripheral blood up to 6 and 3 hours,
respectively, before sequestration within the marrow
space, the process of seeding in the marrow space [21]
extends over 2 to 3 days [20]. During this time, the
homing cells become sessile and presumably begin to
interact with nurturing elements of the marrow
stroma before entering the putative proliferation ver-
sus dormancy checkpoint. Tabulation of repeated im-
aging sessions performed in a group of 54 mice in vivo
showed preferential seeding of transplanted cells in
the periphery of femoral epiphyses as compared with
central locations in the epiphysis or the diaphyseal
marrow (Figure 5). The same topologic predilection
for seeding was observed in excised femurs perfused
with BMC ex vivo and in secondary recipients of
primary BM-homed cells. The brightly ﬂuorescent
cells in the peripheral areas of the marrow for several
weeks indicates that these cells did not undergo cell
division, which would have resulted in dilution of their
ﬂuorescence. These cells were most likely quiescent
stem or primitive progenitor cells, as opposed to ma-
ture nonproliferating cells, because they were seen
after transplantation of lineage-negative cells. Primary
BM-homed cells, which are primitive cells [22,23],
also seeded almost exclusively in peripheral loci within
the epiphysis when transplanted into secondary recip-
ients. Further evidence that the ﬂuorescent cells ob-
served through the optical window are primitive pre-
cursors derives from the observation that within 3
days after transplantation, recipient marrow was en-
riched 2.75-fold in donor SCA-1 lineage-negative
cells as compared with the inoculum of BMC injected
at day 0. This is consistent with previous reports,
which showed that the BM-homed cells are enriched
for stem cells and early progenitors [20-24]. The to-
pologic location of the transplanted cells visualized
through the optical window was not surprising, in
view of the peripheral location of the hematopoietic
stem cells in the marrow of normal (nontransplanted)
mice [2-7]. Further evidence that seeding cells are
primitive progenitors will be obtained in future exper-
iments in which these cells will be selectively har-
vested from various areas of the recipient marrow and
subjected to multiparameter ﬂow cytometry.
The pattern of seeding that we observed could be
explained either by the presence of preferential blood
ﬂow to these areas (stem cells thus seed in the ﬁrst
marrow location that they encounter) or by the pres-
ence of advantaged loci for seeding within the jux-
taosseous marrow space. A recent study attributed this
pattern of seeding to the organization of blood ﬂow
within the marrow space [13]. Nutrient arteries that
penetrate the marrow from the endosteal capillary
network of the bone cortex drain either to the en-
dosteal venous plexus or to the central femoral sinu-
soids, which would suggest that stem cells could elect
either location for seeding. Furthermore, we observed
that stem cells drift freely in the marrow space in the
ﬁrst hours after intravenous infusion [1,20], suggest-
ing that the pattern of blood ﬂow in the femoral cavity
does not inﬂuence the site of eventual stem cell seed-
ing. Ex vivo infusion of stem cells directly into the
marrow cavity resulted in a topology of engraftment
similar to that seen after intravenous BMC infusion,
further showing that seeding the periphery of the
epiphyseal space occurs at sites that offer a particularly
hospitable local milieu. The similar topologic patterns
of primary adhesion in vivo and in isolated femurs in
situ strongly suggest that these favorable microenvi-
ronments for initial cell-stroma interaction are aligned
along the endosteal surface of the epiphyseal bone.
Migration of PKH-labeled cells into central mar-
row zones was observed 4 to 5 days after transplanta-
tion in both primary and secondary recipients. It is
likely that the cells that migrate to these loci are
actively dividing cells, as evidenced by the dilution of
their ﬂuorescence and by the persistence of PKH-
bright mitotically quiescent cells along the periphery
of the marrow space. Actively dividing cells change the
repertoire of their surface adhesion molecules as com-
pared with quiescent cells [25-27], possibly permitting
Figure 5. Seeding of transplanted cells in the host femur. Syngeneic
and allogeneic cells home to the bone marrow during 6 and 3 hours
after intravenous injection, respectively. In the marrow space, the
cells gradually seed in clusters in the subendosteal areas of the
epiphyses over 2 to 3 days. After 4 to 5 days, some clusters are likely
to migrate, are seen in the more central regions of the epiphyses,
and gradually colonize the diaphysis. Secondary seeding is accom-
panied by a decrease in PKH ﬂuorescence intensity and increased
heterogeneity of the ﬂuorescence, suggesting the onset of cellular
division. Some bright ﬂuorescent cells continue to be seeded in the
peripheral areas of the marrow in proximity to the bone cortex for
weeks. These topologic and chronologic patterns of seeding were
integrated on the basis of repeated in vivo imaging of PKH-labeled
cells in the femoral marrow of 54 hosts.
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their migration from the site of initial seeding to other
sites in the marrow. Alternatively, it is possible that
interaction of the cells with the stroma induced recip-
rocal changes in the expression of adhesion molecules,
cytokines, and chemokines [28-30]. Future experi-
ments performed during the migration process should
address this reciprocity and elucidate whether engage-
ment of engrafted stem cells in the cell cycle precedes
or follows migration of the these cells within the
marrow. Use of labeled antibodies reactive against
speciﬁc mediators of adhesion infused in vivo and in
situ will permit dynamic evaluation of the role of the
marrow stroma on the seeding process as observed
through the optical window.
In summary, we performed in vivo monitoring of
the distribution of donor hematopoietic cells after
transplantation in the murine femoral marrow early
after transplantation and after 3 weeks. Intravenously
transplanted cells align along the endosteal bone sur-
face of the epiphyses.
Although some cells remained at this location and
retained bright ﬂuorescence for periods exceeding 3
weeks, most cells migrated to the more central areas of
the epiphyses and to the diaphyses. This process
started 4 to 6 days after transplantation and was ac-
companied by decreased ﬂuorescence, suggesting mi-
totic activity with concomitant dilution of PKH dye
on the daughter cells. Transplanted cells followed
organized topologic and chronologic patterns of seed-
ing in the host bone marrow in syngeneic and alloge-
neic transplantation settings, and the same patterns
were seen in secondary transplantation of initially
homing cells. This pattern was independent of blood
ﬂow within the marrow space. Intravital monitoring of
cells in the bone marrow and at the whole organ level
will [1,31-33] yield new insights into the mechanisms
and patterns of homing, seeding, and engraftment in
physiological conditions and in real time.
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